news semaglutide Trump announces deal to lower cost of weight loss drug Compounding pharmacies to halt semaglutide

Given the success of the FLOW trial, Novo Nordisk has said that it has filed for expanded indications for Ozempic to include the prevention of kidney disease progression in patients with type 2 diabetes and CKD in the European Union and expects to hear about the filing sometime this year

Learn how to talk with your doctor about your weight

10.1096/fj.202401362R Faseb J

For patients wanting deeper insight into how their genetics influence appetite regulation and peptide sensitivity, the Precision Peptide Genetic Test ($298) maps 14 metabolic pathways and analyzes 49 peptides

Dosage Tolerance: Note how your body feels at different stages of the dosage chart